返回
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.（01541.HK）价格
01541.HK 股价走势图
IMMUNEONCO-B (01541.HK)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HK$4.62
-14.12%
$-0.75
休市： Jan 21, 16:00:00 HKT
关键数据
前收盘价
$5.38
开盘价
$5.38
当日区间
$4.55 - $5.39
52周范围
$4.31 - $16.8
交易量
5.4M
平均成交量
2.1M
每股收益（TTM）
-0.93
股息收益率
--
市值
$1.9B
什么是 IMMUNEONCO-B？
ImmuneOnco Biopharmaceuticals (Shanghai), Inc. operates as an early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products. The company is headquartered in Shanghai, Shanghai and currently employs 195 full-time employees. The company went IPO on 2023-09-05. The firm's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The firm's core product IMM01 is an innovative CD47-targeted molecule. The firm mainly operates its businesses in the domestic and overseas markets.